nodes	percent_of_prediction	percent_of_DWPC	metapath
Diatrizoate—Anuria—Vandetanib—thyroid cancer	0.0416	0.0416	CcSEcCtD
Diatrizoate—Cardio-respiratory arrest—Vandetanib—thyroid cancer	0.0407	0.0407	CcSEcCtD
Diatrizoate—Infarction—Sorafenib—thyroid cancer	0.0353	0.0353	CcSEcCtD
Diatrizoate—Respiratory arrest—Vandetanib—thyroid cancer	0.033	0.033	CcSEcCtD
Diatrizoate—Nephropathy—Vandetanib—thyroid cancer	0.0305	0.0305	CcSEcCtD
Diatrizoate—Nephrotic syndrome—Sorafenib—thyroid cancer	0.0203	0.0203	CcSEcCtD
Diatrizoate—Tachyarrhythmia—Epirubicin—thyroid cancer	0.0198	0.0198	CcSEcCtD
Diatrizoate—Tachyarrhythmia—Doxorubicin—thyroid cancer	0.0184	0.0184	CcSEcCtD
Diatrizoate—Haematoma—Sorafenib—thyroid cancer	0.0156	0.0156	CcSEcCtD
Diatrizoate—Respiratory distress—Sorafenib—thyroid cancer	0.0154	0.0154	CcSEcCtD
Diatrizoate—Creatinine increased—Vandetanib—thyroid cancer	0.0153	0.0153	CcSEcCtD
Diatrizoate—Drug interaction—Sorafenib—thyroid cancer	0.0106	0.0106	CcSEcCtD
Diatrizoate—Anuria—Epirubicin—thyroid cancer	0.0104	0.0104	CcSEcCtD
Diatrizoate—Skin necrosis—Epirubicin—thyroid cancer	0.0104	0.0104	CcSEcCtD
Diatrizoate—Cardiac arrest—Vandetanib—thyroid cancer	0.01	0.01	CcSEcCtD
Diatrizoate—Blood creatinine increased—Vandetanib—thyroid cancer	0.00988	0.00988	CcSEcCtD
Diatrizoate—Skin necrosis—Doxorubicin—thyroid cancer	0.00959	0.00959	CcSEcCtD
Diatrizoate—Anuria—Doxorubicin—thyroid cancer	0.00959	0.00959	CcSEcCtD
Diatrizoate—Skin exfoliation—Sorafenib—thyroid cancer	0.00936	0.00936	CcSEcCtD
Diatrizoate—Bronchospasm—Vandetanib—thyroid cancer	0.00897	0.00897	CcSEcCtD
Diatrizoate—Neutropenia—Vandetanib—thyroid cancer	0.00853	0.00853	CcSEcCtD
Diatrizoate—Renal failure—Vandetanib—thyroid cancer	0.00799	0.00799	CcSEcCtD
Diatrizoate—Conjunctivitis—Vandetanib—thyroid cancer	0.0079	0.0079	CcSEcCtD
Diatrizoate—Haematuria—Vandetanib—thyroid cancer	0.00775	0.00775	CcSEcCtD
Diatrizoate—Renal failure acute—Sorafenib—thyroid cancer	0.00771	0.00771	CcSEcCtD
Diatrizoate—Haemoglobin—Vandetanib—thyroid cancer	0.00734	0.00734	CcSEcCtD
Diatrizoate—Haemorrhage—Vandetanib—thyroid cancer	0.0073	0.0073	CcSEcCtD
Diatrizoate—Arrhythmia—Vandetanib—thyroid cancer	0.00652	0.00652	CcSEcCtD
Diatrizoate—Dysgeusia—Vandetanib—thyroid cancer	0.00622	0.00622	CcSEcCtD
Diatrizoate—Lacrimation—Epirubicin—thyroid cancer	0.00616	0.00616	CcSEcCtD
Diatrizoate—Muscle spasms—Vandetanib—thyroid cancer	0.00611	0.00611	CcSEcCtD
Diatrizoate—Tremor—Vandetanib—thyroid cancer	0.00595	0.00595	CcSEcCtD
Diatrizoate—Eruption—Epirubicin—thyroid cancer	0.00589	0.00589	CcSEcCtD
Diatrizoate—Neutropenia—Sorafenib—thyroid cancer	0.00575	0.00575	CcSEcCtD
Diatrizoate—Lacrimation—Doxorubicin—thyroid cancer	0.0057	0.0057	CcSEcCtD
Diatrizoate—Loss of consciousness—Vandetanib—thyroid cancer	0.00558	0.00558	CcSEcCtD
Diatrizoate—Cough—Vandetanib—thyroid cancer	0.00554	0.00554	CcSEcCtD
Diatrizoate—Convulsion—Vandetanib—thyroid cancer	0.0055	0.0055	CcSEcCtD
Diatrizoate—Hypertension—Vandetanib—thyroid cancer	0.00549	0.00549	CcSEcCtD
Diatrizoate—Eruption—Doxorubicin—thyroid cancer	0.00545	0.00545	CcSEcCtD
Diatrizoate—Chest pain—Vandetanib—thyroid cancer	0.00541	0.00541	CcSEcCtD
Diatrizoate—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00541	0.00541	CcSEcCtD
Diatrizoate—Renal failure—Sorafenib—thyroid cancer	0.00539	0.00539	CcSEcCtD
Diatrizoate—Myocardial infarction—Sorafenib—thyroid cancer	0.00538	0.00538	CcSEcCtD
Diatrizoate—Paralysis—Epirubicin—thyroid cancer	0.00522	0.00522	CcSEcCtD
Diatrizoate—Oedema—Vandetanib—thyroid cancer	0.00519	0.00519	CcSEcCtD
Diatrizoate—Infection—Vandetanib—thyroid cancer	0.00515	0.00515	CcSEcCtD
Diatrizoate—Thrombosis—Epirubicin—thyroid cancer	0.00512	0.00512	CcSEcCtD
Diatrizoate—Thrombocytopenia—Vandetanib—thyroid cancer	0.00508	0.00508	CcSEcCtD
Diatrizoate—Haemoglobin—Sorafenib—thyroid cancer	0.00495	0.00495	CcSEcCtD
Diatrizoate—Haemorrhage—Sorafenib—thyroid cancer	0.00492	0.00492	CcSEcCtD
Diatrizoate—Paralysis—Doxorubicin—thyroid cancer	0.00483	0.00483	CcSEcCtD
Diatrizoate—Thrombosis—Doxorubicin—thyroid cancer	0.00474	0.00474	CcSEcCtD
Diatrizoate—Paraesthesia—Vandetanib—thyroid cancer	0.00466	0.00466	CcSEcCtD
Diatrizoate—Dyspnoea—Vandetanib—thyroid cancer	0.00462	0.00462	CcSEcCtD
Diatrizoate—Feeling hot—Epirubicin—thyroid cancer	0.00462	0.00462	CcSEcCtD
Diatrizoate—Necrosis—Epirubicin—thyroid cancer	0.00462	0.00462	CcSEcCtD
Diatrizoate—Flushing—Sorafenib—thyroid cancer	0.00457	0.00457	CcSEcCtD
Diatrizoate—Stinging—Epirubicin—thyroid cancer	0.00447	0.00447	CcSEcCtD
Diatrizoate—Injection site pain—Epirubicin—thyroid cancer	0.00444	0.00444	CcSEcCtD
Diatrizoate—Pain—Vandetanib—thyroid cancer	0.00443	0.00443	CcSEcCtD
Diatrizoate—Petechiae—Epirubicin—thyroid cancer	0.0044	0.0044	CcSEcCtD
Diatrizoate—Arrhythmia—Sorafenib—thyroid cancer	0.0044	0.0044	CcSEcCtD
Diatrizoate—Erythema—Sorafenib—thyroid cancer	0.00429	0.00429	CcSEcCtD
Diatrizoate—Necrosis—Doxorubicin—thyroid cancer	0.00427	0.00427	CcSEcCtD
Diatrizoate—Feeling hot—Doxorubicin—thyroid cancer	0.00427	0.00427	CcSEcCtD
Diatrizoate—Dysgeusia—Sorafenib—thyroid cancer	0.0042	0.0042	CcSEcCtD
Diatrizoate—Extravasation—Epirubicin—thyroid cancer	0.00415	0.00415	CcSEcCtD
Diatrizoate—Stinging—Doxorubicin—thyroid cancer	0.00414	0.00414	CcSEcCtD
Diatrizoate—Vasodilation—Epirubicin—thyroid cancer	0.00412	0.00412	CcSEcCtD
Diatrizoate—Cardiovascular disorder—Epirubicin—thyroid cancer	0.00412	0.00412	CcSEcCtD
Diatrizoate—Vasodilation procedure—Epirubicin—thyroid cancer	0.00412	0.00412	CcSEcCtD
Diatrizoate—Muscle spasms—Sorafenib—thyroid cancer	0.00412	0.00412	CcSEcCtD
Diatrizoate—Injection site pain—Doxorubicin—thyroid cancer	0.00411	0.00411	CcSEcCtD
Diatrizoate—Body temperature increased—Vandetanib—thyroid cancer	0.0041	0.0041	CcSEcCtD
Diatrizoate—Petechiae—Doxorubicin—thyroid cancer	0.00408	0.00408	CcSEcCtD
Diatrizoate—Anaemia—Sorafenib—thyroid cancer	0.00396	0.00396	CcSEcCtD
Diatrizoate—Cough increased—Epirubicin—thyroid cancer	0.00396	0.00396	CcSEcCtD
Diatrizoate—Lacrimation increased—Epirubicin—thyroid cancer	0.00393	0.00393	CcSEcCtD
Diatrizoate—Oliguria—Epirubicin—thyroid cancer	0.00393	0.00393	CcSEcCtD
Diatrizoate—Angioedema—Sorafenib—thyroid cancer	0.00392	0.00392	CcSEcCtD
Diatrizoate—Extravasation—Doxorubicin—thyroid cancer	0.00384	0.00384	CcSEcCtD
Diatrizoate—Leukopenia—Sorafenib—thyroid cancer	0.00384	0.00384	CcSEcCtD
Diatrizoate—Cardiovascular disorder—Doxorubicin—thyroid cancer	0.00382	0.00382	CcSEcCtD
Diatrizoate—Vasodilation—Doxorubicin—thyroid cancer	0.00382	0.00382	CcSEcCtD
Diatrizoate—Vasodilation procedure—Doxorubicin—thyroid cancer	0.00382	0.00382	CcSEcCtD
Diatrizoate—Creatinine increased—Epirubicin—thyroid cancer	0.00381	0.00381	CcSEcCtD
Diatrizoate—Loss of consciousness—Sorafenib—thyroid cancer	0.00377	0.00377	CcSEcCtD
Diatrizoate—Cough—Sorafenib—thyroid cancer	0.00374	0.00374	CcSEcCtD
Diatrizoate—Asthenia—Vandetanib—thyroid cancer	0.00372	0.00372	CcSEcCtD
Diatrizoate—Hypertension—Sorafenib—thyroid cancer	0.0037	0.0037	CcSEcCtD
Diatrizoate—Pruritus—Vandetanib—thyroid cancer	0.00367	0.00367	CcSEcCtD
Diatrizoate—Cough increased—Doxorubicin—thyroid cancer	0.00366	0.00366	CcSEcCtD
Diatrizoate—Lacrimation increased—Doxorubicin—thyroid cancer	0.00364	0.00364	CcSEcCtD
Diatrizoate—Oliguria—Doxorubicin—thyroid cancer	0.00364	0.00364	CcSEcCtD
Diatrizoate—Pulmonary embolism—Epirubicin—thyroid cancer	0.00362	0.00362	CcSEcCtD
Diatrizoate—Diarrhoea—Vandetanib—thyroid cancer	0.00355	0.00355	CcSEcCtD
Diatrizoate—Creatinine increased—Doxorubicin—thyroid cancer	0.00352	0.00352	CcSEcCtD
Diatrizoate—Anaphylactic shock—Sorafenib—thyroid cancer	0.0035	0.0035	CcSEcCtD
Diatrizoate—Infection—Sorafenib—thyroid cancer	0.00348	0.00348	CcSEcCtD
Diatrizoate—Skin exfoliation—Epirubicin—thyroid cancer	0.00346	0.00346	CcSEcCtD
Diatrizoate—Shock—Sorafenib—thyroid cancer	0.00344	0.00344	CcSEcCtD
Diatrizoate—Dizziness—Vandetanib—thyroid cancer	0.00343	0.00343	CcSEcCtD
Diatrizoate—Thrombocytopenia—Sorafenib—thyroid cancer	0.00342	0.00342	CcSEcCtD
Diatrizoate—Pulmonary embolism—Doxorubicin—thyroid cancer	0.00335	0.00335	CcSEcCtD
Diatrizoate—Coma—Epirubicin—thyroid cancer	0.00331	0.00331	CcSEcCtD
Diatrizoate—Vomiting—Vandetanib—thyroid cancer	0.0033	0.0033	CcSEcCtD
Diatrizoate—Rash—Vandetanib—thyroid cancer	0.00327	0.00327	CcSEcCtD
Diatrizoate—Dermatitis—Vandetanib—thyroid cancer	0.00327	0.00327	CcSEcCtD
Diatrizoate—Headache—Vandetanib—thyroid cancer	0.00325	0.00325	CcSEcCtD
Diatrizoate—Pulmonary oedema—Epirubicin—thyroid cancer	0.00323	0.00323	CcSEcCtD
Diatrizoate—Skin exfoliation—Doxorubicin—thyroid cancer	0.0032	0.0032	CcSEcCtD
Diatrizoate—Dyspnoea—Sorafenib—thyroid cancer	0.00312	0.00312	CcSEcCtD
Diatrizoate—Nausea—Vandetanib—thyroid cancer	0.00308	0.00308	CcSEcCtD
Diatrizoate—Coma—Doxorubicin—thyroid cancer	0.00306	0.00306	CcSEcCtD
Diatrizoate—Thrombophlebitis—Epirubicin—thyroid cancer	0.00304	0.00304	CcSEcCtD
Diatrizoate—Pain—Sorafenib—thyroid cancer	0.00299	0.00299	CcSEcCtD
Diatrizoate—Pulmonary oedema—Doxorubicin—thyroid cancer	0.00298	0.00298	CcSEcCtD
Diatrizoate—Renal failure acute—Epirubicin—thyroid cancer	0.00285	0.00285	CcSEcCtD
Diatrizoate—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00281	0.00281	CcSEcCtD
Diatrizoate—Urticaria—Sorafenib—thyroid cancer	0.00278	0.00278	CcSEcCtD
Diatrizoate—Body temperature increased—Sorafenib—thyroid cancer	0.00277	0.00277	CcSEcCtD
Diatrizoate—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00272	0.00272	CcSEcCtD
Diatrizoate—Renal failure acute—Doxorubicin—thyroid cancer	0.00264	0.00264	CcSEcCtD
Diatrizoate—Face oedema—Epirubicin—thyroid cancer	0.00254	0.00254	CcSEcCtD
Diatrizoate—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00251	0.00251	CcSEcCtD
Diatrizoate—Asthenia—Sorafenib—thyroid cancer	0.00251	0.00251	CcSEcCtD
Diatrizoate—Cardiac arrest—Epirubicin—thyroid cancer	0.0025	0.0025	CcSEcCtD
Diatrizoate—Pruritus—Sorafenib—thyroid cancer	0.00247	0.00247	CcSEcCtD
Diatrizoate—Blood creatinine increased—Epirubicin—thyroid cancer	0.00246	0.00246	CcSEcCtD
Diatrizoate—Diarrhoea—Sorafenib—thyroid cancer	0.00239	0.00239	CcSEcCtD
Diatrizoate—Face oedema—Doxorubicin—thyroid cancer	0.00235	0.00235	CcSEcCtD
Diatrizoate—Cardiac arrest—Doxorubicin—thyroid cancer	0.00231	0.00231	CcSEcCtD
Diatrizoate—Dizziness—Sorafenib—thyroid cancer	0.00231	0.00231	CcSEcCtD
Diatrizoate—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00228	0.00228	CcSEcCtD
Diatrizoate—Asthma—Epirubicin—thyroid cancer	0.00227	0.00227	CcSEcCtD
Diatrizoate—Vomiting—Sorafenib—thyroid cancer	0.00222	0.00222	CcSEcCtD
Diatrizoate—Rash—Sorafenib—thyroid cancer	0.00221	0.00221	CcSEcCtD
Diatrizoate—Dermatitis—Sorafenib—thyroid cancer	0.0022	0.0022	CcSEcCtD
Diatrizoate—Headache—Sorafenib—thyroid cancer	0.00219	0.00219	CcSEcCtD
Diatrizoate—Neutropenia—Epirubicin—thyroid cancer	0.00213	0.00213	CcSEcCtD
Diatrizoate—Asthma—Doxorubicin—thyroid cancer	0.0021	0.0021	CcSEcCtD
Diatrizoate—Nausea—Sorafenib—thyroid cancer	0.00208	0.00208	CcSEcCtD
Diatrizoate—Renal failure—Epirubicin—thyroid cancer	0.00199	0.00199	CcSEcCtD
Diatrizoate—Conjunctivitis—Epirubicin—thyroid cancer	0.00197	0.00197	CcSEcCtD
Diatrizoate—Neutropenia—Doxorubicin—thyroid cancer	0.00197	0.00197	CcSEcCtD
Diatrizoate—Sweating—Epirubicin—thyroid cancer	0.00194	0.00194	CcSEcCtD
Diatrizoate—Haematuria—Epirubicin—thyroid cancer	0.00193	0.00193	CcSEcCtD
Diatrizoate—Renal failure—Doxorubicin—thyroid cancer	0.00184	0.00184	CcSEcCtD
Diatrizoate—Haemoglobin—Epirubicin—thyroid cancer	0.00183	0.00183	CcSEcCtD
Diatrizoate—Rhinitis—Epirubicin—thyroid cancer	0.00182	0.00182	CcSEcCtD
Diatrizoate—Conjunctivitis—Doxorubicin—thyroid cancer	0.00182	0.00182	CcSEcCtD
Diatrizoate—Haemorrhage—Epirubicin—thyroid cancer	0.00182	0.00182	CcSEcCtD
Diatrizoate—Hypoaesthesia—Epirubicin—thyroid cancer	0.00181	0.00181	CcSEcCtD
Diatrizoate—Sweating—Doxorubicin—thyroid cancer	0.0018	0.0018	CcSEcCtD
Diatrizoate—Haematuria—Doxorubicin—thyroid cancer	0.00179	0.00179	CcSEcCtD
Diatrizoate—Haemoglobin—Doxorubicin—thyroid cancer	0.00169	0.00169	CcSEcCtD
Diatrizoate—Flushing—Epirubicin—thyroid cancer	0.00169	0.00169	CcSEcCtD
Diatrizoate—Rhinitis—Doxorubicin—thyroid cancer	0.00169	0.00169	CcSEcCtD
Diatrizoate—Haemorrhage—Doxorubicin—thyroid cancer	0.00168	0.00168	CcSEcCtD
Diatrizoate—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00168	0.00168	CcSEcCtD
Diatrizoate—Chills—Epirubicin—thyroid cancer	0.00163	0.00163	CcSEcCtD
Diatrizoate—Arrhythmia—Epirubicin—thyroid cancer	0.00163	0.00163	CcSEcCtD
Diatrizoate—Erythema—Epirubicin—thyroid cancer	0.00158	0.00158	CcSEcCtD
Diatrizoate—Flushing—Doxorubicin—thyroid cancer	0.00156	0.00156	CcSEcCtD
Diatrizoate—Dysgeusia—Epirubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
Diatrizoate—Muscle spasms—Epirubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Diatrizoate—Chills—Doxorubicin—thyroid cancer	0.00151	0.00151	CcSEcCtD
Diatrizoate—Arrhythmia—Doxorubicin—thyroid cancer	0.0015	0.0015	CcSEcCtD
Diatrizoate—Erythema—Doxorubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Diatrizoate—Anaemia—Epirubicin—thyroid cancer	0.00146	0.00146	CcSEcCtD
Diatrizoate—Agitation—Epirubicin—thyroid cancer	0.00146	0.00146	CcSEcCtD
Diatrizoate—Dysgeusia—Doxorubicin—thyroid cancer	0.00144	0.00144	CcSEcCtD
Diatrizoate—Leukopenia—Epirubicin—thyroid cancer	0.00142	0.00142	CcSEcCtD
Diatrizoate—Muscle spasms—Doxorubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Diatrizoate—Loss of consciousness—Epirubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Diatrizoate—Cough—Epirubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Diatrizoate—Convulsion—Epirubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Diatrizoate—Hypertension—Epirubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Diatrizoate—Anaemia—Doxorubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Diatrizoate—Chest pain—Epirubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Diatrizoate—Agitation—Doxorubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Diatrizoate—Leukopenia—Doxorubicin—thyroid cancer	0.00131	0.00131	CcSEcCtD
Diatrizoate—Confusional state—Epirubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Diatrizoate—Anaphylactic shock—Epirubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Diatrizoate—Oedema—Epirubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Diatrizoate—Loss of consciousness—Doxorubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Diatrizoate—Infection—Epirubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Diatrizoate—Cough—Doxorubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Diatrizoate—Shock—Epirubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Diatrizoate—Convulsion—Doxorubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Diatrizoate—Thrombocytopenia—Epirubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Diatrizoate—Hypertension—Doxorubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Diatrizoate—Tachycardia—Epirubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Diatrizoate—Hyperhidrosis—Epirubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Diatrizoate—Chest pain—Doxorubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Diatrizoate—Hypotension—Epirubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Diatrizoate—Confusional state—Doxorubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Diatrizoate—Anaphylactic shock—Doxorubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Diatrizoate—Oedema—Doxorubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Diatrizoate—Infection—Doxorubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Diatrizoate—Shock—Doxorubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Diatrizoate—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Diatrizoate—Tachycardia—Doxorubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Diatrizoate—Paraesthesia—Epirubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Diatrizoate—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Diatrizoate—Dyspnoea—Epirubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Diatrizoate—Hypotension—Doxorubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Diatrizoate—Pain—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Diatrizoate—Paraesthesia—Doxorubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Diatrizoate—Dyspnoea—Doxorubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Diatrizoate—Feeling abnormal—Epirubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Diatrizoate—Urticaria—Epirubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Diatrizoate—Pain—Doxorubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Diatrizoate—Body temperature increased—Epirubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Diatrizoate—Feeling abnormal—Doxorubicin—thyroid cancer	0.000986	0.000986	CcSEcCtD
Diatrizoate—Urticaria—Doxorubicin—thyroid cancer	0.00095	0.00095	CcSEcCtD
Diatrizoate—Body temperature increased—Doxorubicin—thyroid cancer	0.000946	0.000946	CcSEcCtD
Diatrizoate—Asthenia—Epirubicin—thyroid cancer	0.000927	0.000927	CcSEcCtD
Diatrizoate—Pruritus—Epirubicin—thyroid cancer	0.000915	0.000915	CcSEcCtD
Diatrizoate—Diarrhoea—Epirubicin—thyroid cancer	0.000884	0.000884	CcSEcCtD
Diatrizoate—Asthenia—Doxorubicin—thyroid cancer	0.000858	0.000858	CcSEcCtD
Diatrizoate—Dizziness—Epirubicin—thyroid cancer	0.000855	0.000855	CcSEcCtD
Diatrizoate—Pruritus—Doxorubicin—thyroid cancer	0.000846	0.000846	CcSEcCtD
Diatrizoate—Vomiting—Epirubicin—thyroid cancer	0.000822	0.000822	CcSEcCtD
Diatrizoate—Diarrhoea—Doxorubicin—thyroid cancer	0.000818	0.000818	CcSEcCtD
Diatrizoate—Rash—Epirubicin—thyroid cancer	0.000815	0.000815	CcSEcCtD
Diatrizoate—Dermatitis—Epirubicin—thyroid cancer	0.000814	0.000814	CcSEcCtD
Diatrizoate—Headache—Epirubicin—thyroid cancer	0.00081	0.00081	CcSEcCtD
Diatrizoate—Dizziness—Doxorubicin—thyroid cancer	0.000791	0.000791	CcSEcCtD
Diatrizoate—Nausea—Epirubicin—thyroid cancer	0.000768	0.000768	CcSEcCtD
Diatrizoate—Vomiting—Doxorubicin—thyroid cancer	0.000761	0.000761	CcSEcCtD
Diatrizoate—Rash—Doxorubicin—thyroid cancer	0.000754	0.000754	CcSEcCtD
Diatrizoate—Dermatitis—Doxorubicin—thyroid cancer	0.000753	0.000753	CcSEcCtD
Diatrizoate—Headache—Doxorubicin—thyroid cancer	0.000749	0.000749	CcSEcCtD
Diatrizoate—Nausea—Doxorubicin—thyroid cancer	0.00071	0.00071	CcSEcCtD
